明日主题前瞻 4、POE | 据报道，刚刚步入7月，不少化工原料悄然提价，多个化工巨头带头发函涨价。近期陶氏、LG化学、SK三家巨头齐发涨价函，POE（聚烯烃弹性 体）涨幅超过1000元/吨。陶氏、LG化学发布公告表示，而近期全球地缘政治不确定性加剧了上游市场的波动，7月1日起，亚太地区产品每吨涨价150美元 （约1075元/吨）；SK称，为保障品质，7月1日起，中国地区POE每吨上调1000元。今年以来，LG化学、陶氏化学等国际企业纷纷上调POE价格，推动国内 POE价格被动上涨。 点评：据中证报，POE兼具塑料和橡胶性质，为一种高性能热塑性弹性体，属于高端聚烯烃产品，近年来在光伏、汽车、包装等领域需求激增。据华经产业 研究院数据，我国POE在光伏领域应用占比为40%，汽车行业应用占比为26%，光伏应用已经成为POE最主要应用领域。POE 在光伏领域中主要用于封装胶 膜。N型电池+双玻组件渗透率提升，光伏用POE需求显著提升。中国目前对POE的进口依赖度超80%，国产化市场空间广阔。 5、元宇宙 | 据证券时报，工业和信息化部办公厅、教育部办公厅、文化和旅游部办公厅、广电总局办公厅发布关于组织开展2025年 ...

3、中国有色金属工业协会硅业分会报道，目前硅片价格几乎低于所有在产硅片企业现金成本，企业挺 价意愿较强；低价行情下，硅片厂减产力度明显增强。 4、工信部召开第十五次制造业企业座谈会强调，依法依规、综合治理光伏行业低价无序竞争，引导企 业提升产品品质，推动落后产能有序退出。 5、美越贸易协定将对转运货物征收40%关税，外交部对此表示，中方一贯主张各方通过平等对话，协 商解决经贸分歧，同时有关谈判和协议不应针对或损害第三方的利益。 6、3天2板未名医药：公司存在触发其他风险警示的情形。财富趋势：实际控制人兼董事长拟减持不超 过3%公司股份。2连板亚玛顿："光伏玻璃行业部分企业阶段性下调产能"的采访中 未涉及公司自身的生 产安排或业绩预测。3天2板华银电力：预计半年度归母净利润1.8亿-2.2亿元（未经审计）。2连板巨力 索具：公司不存在违反信息公平披露的情形。6连板诚邦股份：控股股东方利强与一致行动人质押比例 较高。万科A：向深铁集团申请不超过62.49亿元借款并展期部分已有借款。8天6板大东南：公司产品 CPP铝塑膜适用于固态锂电池的封装 但目前并未生产该产品。 智通财经7月3日晚间新闻精选 1、国家药监局发布 ...

重要的消息有哪些 1．7月3日下午，商务部召开例行新闻发布会，有记者就有关美国总统拟带企业团访华的报道进行提 问。商务部新闻发言人何咏前：关于这个问题，我没有可以提供的信息，但是中方的态度是一贯的且明 确的。希望美方与中方相向而行，在两国元首的战略引领下，本着相互尊重、和平共处、合作共赢的原 则，不断增进共识，减少误解，加强合作，共同推动中美经贸关系健康、稳定、可持续发展。 2．据美国彭博社7月3日援引西门子公司的消息证实，美国政府已解除对华芯片设计软件出口的许可证 要求。西门子公司称，美国商务部已通知全球三大芯片设计软件供应商——新思科技、楷登电子和西门 子，此前要求其在华业务必须申请政府许可的规定现已撤销。西门子公司表示已全面恢复中国客户对其 软件和技术的访问权限，新思科技与楷登电子称正在逐步重启相关服务。 3．国务院新闻办公室将于2025年7月4日（星期五）下午3时举行国务院政策例行吹风会，请商务部部长 助理唐文弘，上海市委常委、常务副市长吴伟和中国人民银行、海关总署有关负责人介绍中国（上海） 自由贸易试验区全面对接国际高标准经贸规则试点成效及复制推广有关情况，并答记者问。 4．商务部服贸司负责人介绍2 ...

www.leadleo.com 中国医疗科技行业调研简报 | 2025/05 Q1：脑机接口柔性电极有哪些分类？ 图表1：柔性电极内部构造 报告标签：柔性电极、信号监测、微电极 2025年5月 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另行标明出处者除外）。未经头豹 研究院事先书面许可，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究 院保留采取法律措施、追究相关人员责任的权利。头豹研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名 称之外的其他分支机构，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 1 头豹调研简报 | 2025/05 医疗科技行业 柔 性 聚 合 物 基 底 金 属 导 电 层 绝 缘 封 装 层 ◼ 根据放置位置不同，颅内柔性电极可分为侵入式 电极和半侵入式电极，颅外柔性电极则包括干电 极、半干电极以及湿电极。每一种电极类型在脑 机接口应用中承担着不同的角色，且各自具备独 特的优势和适用场景 ➢ 颅内电极 侵入式电 ...

Core Viewpoint - The National Medical Products Administration (NMPA) of China is implementing special reviews for high-end medical devices that are domestically innovative, internationally leading, and have significant clinical application value to support their development and international expansion [1][2][3] Regulatory Measures - The NMPA has announced ten key measures focusing on the entire lifecycle regulation of high-end medical devices, including optimizing review and approval processes, strengthening post-market supervision, and enhancing standard system construction [1][2] - The approval time for clinical trials of medical devices has been reduced from 60 working days to 30 working days, with a focus on advancing the review process to the product development stage [2][3] Innovation and Approval Process - Since 2014, the number of approved innovative medical devices has significantly increased from 33 to 323 by April 2023, indicating a rapid acceleration in technology breakthroughs and product launches in high-end medical devices [3] - The NMPA will continue to implement special reviews for high-end innovative medical devices, ensuring priority processing under the principles of early intervention, dedicated responsibility, and scientific review [3][4] Standardization and Guidance - The NMPA aims to enhance standardization research to help domestic high-end medical devices compete internationally, emphasizing the need for improved registration and classification guidance [4][5] - Key areas of focus for standardization include artificial intelligence, brain-computer interfaces, and new biological materials, with plans to establish technical organizations for standardization in these fields [5][6] Post-Market Supervision - The NMPA will strengthen post-market supervision requirements for innovative medical devices, encouraging manufacturers to conduct post-market evaluations and real-world studies to enhance product safety and reliability [5][6] - The regulatory framework will also be improved to support companies in expanding their international market presence, including policies related to export sales certification [6]

Core Viewpoint - The article discusses the recent fluctuations in the A-share market, highlighting the impact of U.S.-Vietnam trade agreements and the performance of specific sectors, particularly consumer electronics and innovative pharmaceuticals. Market Overview - The A-share market experienced a rebound, with the Shanghai Composite Index rising by 0.18%, the Shenzhen Component Index increasing by 1.17%, and the ChiNext Index up by 1.9% [5] - The total market turnover was 13,336 billion, a decrease of 716 billion from the previous day, with over 3,200 stocks rising [5] - A total of 66 stocks hit the daily limit up, with 14 stocks achieving consecutive limit ups, the highest being six consecutive limit ups [5] Sector Performance - The consumer electronics sector saw a collective surge, with stocks like Industrial Fulian, New Asia Electronics, and Chaoyang Technology hitting the daily limit up [5] - The PCB sector also rebounded, with stocks such as Zhongjing Electronics, Bomin Electronics, and Yihua New Materials reaching the daily limit up, driven by speculation on future demand for AI-PCB [5] - Innovative pharmaceutical stocks continued their strong performance, with companies like Guosheng Tang and Changchun High-tech also hitting the daily limit up [5] Trade Policy Impact - The U.S. has lifted restrictions on EDA and ethane exports to China, while Trump announced a trade agreement with Vietnam, which will impose a 20% tariff on Vietnamese exports to the U.S. [1][2] - This policy shift is seen as beneficial for consumer electronics companies with operations in Vietnam, such as Luxshare Precision, which had previously invested in production capacity there [2] Investment Trends - Morgan Stanley's MSCI China Index has risen by 32% over the past year, indicating a recovery in consumer spending and addressing overcapacity issues [7] - The article notes that the current market environment is conducive to a potential supply-side reform, with a focus on key sectors such as automotive, materials, and technology [8][9] Capital Market Dynamics - The article highlights that despite the return to average price-to-earnings ratios, the equity risk premium remains high, suggesting that the Chinese stock market is still undervalued [9] - The low interest rates are expected to continue, with predictions of further rate cuts, which could lead to a shift in investment towards growth stocks as overall return on equity improves [9]

Group 1: Industry Insights - The domestic four-legged robot industry is rapidly developing, with consumer-level models starting at 10,000 yuan [2] - The four-legged robots can be categorized into hydraulic and electric drive types, with electric drive becoming a new trend due to its lower cost and ease of control [3] - The four-legged robot industry has made progress in recent years, but still lacks advanced task planning capabilities and has limited battery life of 8 to 12 hours [4] Group 2: Company Developments - Cloud Deep Technology has delivered over 1,000 units of its "Xie Ying" series products, showcasing its strong presence in various application scenarios [1] - Chip Original Co., Ltd. is recognized as China's leading semiconductor IP company, with a significant increase in its customer base and revenue from chip design and mass production services [8] - Brain Machine Interface technology is gaining traction in China, with various local companies making strides in both non-invasive and invasive applications [6][7]

更多精彩内容请关注格林大华期货官方微信 格林大华期货研究院 证监许可【2011】1288 号 2025 年 7 月 3 日星期四 研究员： 于军礼 从业资格： F0247894 交易咨询资格：Z0000112 联系方式：yujunli@greendh.com 早盘提示 Morning session notice | 板块 | 品种 | 多（空） | | | --- | --- | --- | --- | | | | | 【重要资讯】 | | | | | 1、美国国会参议院以 1 票的微弱优势表决通过了"大而美"税收与支出法案。一 | | | | | 些民主党参议员指责参议院版本法案是"劫贫济富"。 | | | | | 2、美国 5 月 JOLTS 职位空缺 776.9 万人，高于预期的 730 万人，本次 JOLTS 数据 | | | | | 超过了媒体对所有经济学家调查的预期。5 月份自主离职人数从 321.5 万增至 329.3 | | | | | 万。自主离职的人数越高，表明劳动力市场越紧张。 | | | | | 3、高盛表示，受流动性改善、波动性下降、衰退担忧消退以及季节性因素的推动， | | | ...

通过微小电流让脑细胞和计算机之间"互动"、通过连接脑电活动促进局部瘫痪患者康复、通过脑机接口 让渐冻症患者"自主"交流、通过微创给药"一针下去"让全盲患者重见光明、通过基因方式治疗难治性疼 痛和重度癫痫……这些科幻世界里的场景，在北京脑科学与类脑研究所科研工作者努力下，正一步步变 成现实。 6月19日，2025年"活力中国调研行"采访团来到位于北京昌平区中关村生命科学园的北京脑科学与类脑 研究所。走进一层的开放空间，首先映入记者眼帘的是满壁的科研人员的学术简介。正是他们不断解码 大脑的"摩斯密码"，在脑机接口与脑科学等新技术领域屡创生命奇迹。 据北京脑科学与类脑研究所所长罗敏敏介绍，脑机接口是各发达国家在脑科学与类脑科技领域的竞争高 地。由于涉及电极、芯片、数据、算法、分析软件、生物相容性材料等各个环节，脑机接口产品链路 长，部分关键技术存在瓶颈，临床验证、监管和标准也有待完善，系统研发挑战重重。近年来，北京市 研究部署脑机接口重大科技战略，由北京脑科学与类脑研究所牵头规划"智能脑机系统增强计划"，成立 北京芯智达神经技术有限公司，面向国际前沿研发核心部件。今年，主要成果"北脑一号"已进入临床验 证阶段。 " ...

金 融 期 货 研 究 2025 年 7 月 3 日 期指：维持震荡格局 毛磊 投资咨询从业资格号：Z0011222 maolei@gtht.com 【期指期现数据跟踪】 期指数据 | | 收盘价 | 涨跌幅% | 基 差 | 成交额-亿 | 成交量 | 变 动 | 持仓量 | 变 动 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 沪深300 | 3943.68 | ↑0.02 | | 2466.4 | | | | | | IF2507 | 3921 | ↑0.15 | -22.68 | 319 | 27158 | ↓844 | 60669 | ↓329 | | IF2508 | 3903.2 | ↑0.10 | -40.48 | 21.9 | 1869 | ↓37 | 4174 | ↓54 | | IF2509 | 3894.2 | ↑0.12 | -49.48 | 411.7 | 35301 | ↑743 | 133038 | ↑61 | | IF2512 | 3856.2 | ↑0.04 | -87.48 | 74.8 | 647 ...